Dazhi Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Education & Training
- University of IowaPharmD, 2012
Publications & Presentations
PubMed
- 66 citationsEntrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors.Dazhi Liu, Michael Offin, Stephen Harnicar, Bob T. Li, Alexander Drilon> ;Therapeutics and Clinical Risk Management. 2018 Jul 20
- 21 citationsTumor-Agnostic Drug DevelopmentMichael Offin, Dazhi Liu, Alexander Drilon> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2018 May 23
Office
1275 York Ave
New York, NY 10065Phone+1 609-480-6497- Is this information wrong?
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: